FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2510130721> ?p ?o ?g. }

• W2510130721 endingPage "69421" @default.
• W2510130721 startingPage "69408" @default.
• W2510130721 abstract "// Petra Schneiderova 1, * , Tomas Pika 2, * , Petr Gajdos 3 , Regina Fillerova 1 , Pavel Kromer 3 , Milos Kudelka 3 , Jiri Minarik 2 , Tomas Papajik 2 , Vlastimil Scudla 2 and Eva Kriegova 1 1 Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic 2 Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic 3 Department of Computer Science, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, Ostrava, Czech Republic * These authors have contributed equally to this work Correspondence to: Eva Kriegova, email: eva.kriegova@email.cz Keywords: serum pattern, cytokines, growth factors, proximity extension immunoassay, post-transplant serum pattern Received: May 04, 2016     Accepted: July 28, 2016     Published: August 12, 2016 ABSTRACT Serum protein fingerprints associated with MGUS and MM and their changes in MM after autologous stem cell transplantation (MM-ASCT, day 100) remain unexplored. Using highly-sensitive Proximity Extension ImmunoAssay on 92 cancer biomarkers (Proseek Multiplex, Olink), enhanced serum levels of Adrenomedullin (ADM, P corr = .0004), Growth differentiation factor 15 (GDF15, P corr = .003), and soluble Major histocompatibility complex class I-related chain A (sMICA, P corr = .023), all prosurvival and chemoprotective factors for myeloma cells, were detected in MM comparing to MGUS. Comparison of MGUS and healthy subjects revealed elevation of angiogenic and antia-poptotic midkine ( P corr = .0007) and downregulation of Transforming growth factor beta 1 (TGFB1, P corr = .005) in MGUS. Importantly, altered serum pattern was associated with MM-ASCT compared to paired MM at the diagnosis as well as to healthy controls, namely by upregulated B-Cell Activating Factor (sBAFF) ( P corr < .006) and sustained elevation of other pro-tumorigenic factors. In conclusion, the serum fingerprints of MM and MM-ASCT were characteristic by elevated levels of prosurvival and chemoprotective factors for myeloma cells." @default.
• W2510130721 created "2016-09-16" @default.
• W2510130721 creator A5008289460 @default.
• W2510130721 creator A5016480427 @default.
• W2510130721 creator A5023239518 @default.
• W2510130721 creator A5045681315 @default.
• W2510130721 creator A5054131585 @default.
• W2510130721 creator A5056523918 @default.
• W2510130721 creator A5063380340 @default.
• W2510130721 creator A5065521187 @default.
• W2510130721 creator A5085241368 @default.
• W2510130721 creator A5088934266 @default.
• W2510130721 date "2016-08-12" @default.
• W2510130721 modified "2023-10-15" @default.
• W2510130721 title "Serum protein fingerprinting by PEA immunoassay coupled with a pattern-recognition algorithms distinguishes MGUS and multiple myeloma" @default.
• W2510130721 cites W1481809543 @default.
• W2510130721 cites W1514428065 @default.
• W2510130721 cites W1551790359 @default.
• W2510130721 cites W1953823780 @default.
• W2510130721 cites W1963940744 @default.
• W2510130721 cites W1983235956 @default.
• W2510130721 cites W1986625799 @default.
• W2510130721 cites W1992496731 @default.
• W2510130721 cites W1992938093 @default.
• W2510130721 cites W2004487716 @default.
• W2510130721 cites W2005314920 @default.
• W2510130721 cites W2008095107 @default.
• W2510130721 cites W2010084870 @default.
• W2510130721 cites W2015785882 @default.
• W2510130721 cites W2021073309 @default.
• W2510130721 cites W2024044836 @default.
• W2510130721 cites W2028230388 @default.
• W2510130721 cites W2029047196 @default.
• W2510130721 cites W2031692900 @default.
• W2510130721 cites W2032186740 @default.
• W2510130721 cites W2034562931 @default.
• W2510130721 cites W2037050131 @default.
• W2510130721 cites W2048064990 @default.
• W2510130721 cites W2068282005 @default.
• W2510130721 cites W2070135451 @default.
• W2510130721 cites W2087025602 @default.
• W2510130721 cites W2116239490 @default.
• W2510130721 cites W2116619860 @default.
• W2510130721 cites W2117425693 @default.
• W2510130721 cites W2128396804 @default.
• W2510130721 cites W2137310532 @default.
• W2510130721 cites W2138981031 @default.
• W2510130721 cites W2144728882 @default.
• W2510130721 cites W2159860846 @default.
• W2510130721 cites W2164807675 @default.
• W2510130721 cites W2169987170 @default.
• W2510130721 cites W2171830139 @default.
• W2510130721 cites W2380693987 @default.
• W2510130721 cites W2414601702 @default.
• W2510130721 cites W2470939022 @default.
• W2510130721 cites W4233063638 @default.
• W2510130721 doi "https://doi.org/10.18632/oncotarget.11242" @default.
• W2510130721 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5642488" @default.
• W2510130721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29050213" @default.
• W2510130721 hasPublicationYear "2016" @default.
• W2510130721 type Work @default.
• W2510130721 sameAs 2510130721 @default.
• W2510130721 citedByCount "14" @default.
• W2510130721 countsByYear W25101307212016 @default.
• W2510130721 countsByYear W25101307212017 @default.
• W2510130721 countsByYear W25101307212018 @default.
• W2510130721 countsByYear W25101307212019 @default.
• W2510130721 countsByYear W25101307212020 @default.
• W2510130721 countsByYear W25101307212021 @default.
• W2510130721 countsByYear W25101307212022 @default.
• W2510130721 countsByYear W25101307212023 @default.
• W2510130721 crossrefType "journal-article" @default.
• W2510130721 hasAuthorship W2510130721A5008289460 @default.
• W2510130721 hasAuthorship W2510130721A5016480427 @default.
• W2510130721 hasAuthorship W2510130721A5023239518 @default.
• W2510130721 hasAuthorship W2510130721A5045681315 @default.
• W2510130721 hasAuthorship W2510130721A5054131585 @default.
• W2510130721 hasAuthorship W2510130721A5056523918 @default.
• W2510130721 hasAuthorship W2510130721A5063380340 @default.
• W2510130721 hasAuthorship W2510130721A5065521187 @default.
• W2510130721 hasAuthorship W2510130721A5085241368 @default.
• W2510130721 hasAuthorship W2510130721A5088934266 @default.
• W2510130721 hasBestOaLocation W25101307211 @default.
• W2510130721 hasConcept C121608353 @default.
• W2510130721 hasConcept C126322002 @default.
• W2510130721 hasConcept C142724271 @default.
• W2510130721 hasConcept C143998085 @default.
• W2510130721 hasConcept C159654299 @default.
• W2510130721 hasConcept C203014093 @default.
• W2510130721 hasConcept C2776364478 @default.
• W2510130721 hasConcept C2780420688 @default.
• W2510130721 hasConcept C2911091166 @default.
• W2510130721 hasConcept C71924100 @default.
• W2510130721 hasConceptScore W2510130721C121608353 @default.
• W2510130721 hasConceptScore W2510130721C126322002 @default.
• W2510130721 hasConceptScore W2510130721C142724271 @default.
• W2510130721 hasConceptScore W2510130721C143998085 @default.
• W2510130721 hasConceptScore W2510130721C159654299 @default.

• next